OTCMKTS:CURLF

Curaleaf Stock Forecast, Price & News

$13.84
-0.16 (-1.14 %)
(As of 04/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$13.45
Now: $13.84▼
$14.01
50-Day Range
$14.00
MA: $15.40▼
$17.01
52-Week Range
$3.60
Now: $13.84▼
$18.38
Volume969,501 shs
Average Volume1.42 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Curaleaf Holdings, Inc. operates as an integrated medical and wellness cannabis operator in the United States. It operates in two segments, Cannabis Operations and Non-Cannabis Operations. The Cannabis Operations segment engages in the production and sale of cannabis through retail and wholesale channels. The Non-Cannabis Operations segment provides professional services, including cultivation, processing, and retail know-how and back office administration, intellectual property licensing, real estate leasing services, and lending facilities to medical and adult-use cannabis licensees under management service agreements. It offers oils for vaporizing, cartridges, tinctures, capsules, and ground-flower. The company also provides hemp-based CBD products. As of March 9, 2021, it operated 101 dispensaries, 23 cultivation sites, and 30 processing sites in 23 states of the United States. The company was founded in 2010 and is headquartered in Wakefield, Massachusetts.
Curaleaf logo

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:CURLF
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.curaleaf.com
Phone781-451-0150
EmployeesN/A
Year FoundedN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

Headlines

Whatever You Believe About Sundial Growers, You Could Be Right (CURLF)
March 18, 2021 |  marketbeat.com
Today’s Top Buy: Curaleaf - The Motley Fool Canada
April 16, 2021 |  fool.ca
Premium Cannabis Company Sets Out to Transform the Cannabis Experience with Unique Franchise Model - Benzinga
April 15, 2021 |  benzinga.com
Cannabis Expert Alfredo Pascual Joins FastForward Innovations As VP Of Investment Analysis - Benzinga
April 12, 2021 |  benzinga.com
Curaleaf Holdings, Inc. (OTCMKTS:CURLF) Receives Consensus Rating of "Buy" from Brokerages
April 11, 2021 |  americanbankingnews.com
The Week In Cannabis: Glass House, Canopy, Curaleaf, Trulieve, Virginia And More - Yahoo Finance
April 9, 2021 |  finance.yahoo.com
The Week In Cannabis: Glass House, Canopy, Curaleaf, Trulieve, Virginia And More - Benzinga
April 9, 2021 |  benzinga.com
3 Pot Stocks Looking To Bounce - Benzinga
April 9, 2021 |  benzinga.com
Cannabis Dispensary Openings: Trulieve, Ayr, High Tide, Cookies, MedMen, Curaleaf, Inner Spirit, C3 Industries - Benzinga
April 8, 2021 |  benzinga.com
Curaleaf Holdings, Inc. (CURLF) Opens Two New Retail Locations in Greater Philadelphia and Finalizes Rebrand of Nine Retail Locations in Pennsylvania - StreetInsider.com
April 8, 2021 |  streetinsider.com
Curaleaf Opens Two New Retail Locations in Greater Philadelphia and Finalizes Rebrand of Nine Retail Locations in Pennsylvania
April 8, 2021 |  finance.yahoo.com
Curaleaf closes EMMAC acquisition, secures $130M investment from single institutional investor - Seeking Alpha
April 8, 2021 |  seekingalpha.com
European Cannabis growth is not far behind the U.S.: Curaleaf Chairman - Bloomberg
April 7, 2021 |  bloomberg.com
Curaleaf To Enter Europe After Closing $310M EMMAC Acquisition, $130M Financing - Benzinga
April 7, 2021 |  benzinga.com
Curaleaf Completes Acquisition of EMMAC and Secures US$130 Million Investment from a Single Strategic Institutional Investor
April 7, 2021 |  finance.yahoo.com
Planet 13 Posts Q4 Results, Touting Single-Month Record In March; CEO Says 'Las Vegas Is Back' - Benzinga
April 6, 2021 |  benzinga.com
Curaleaf Holdings: One Of New York Cannabis Legalization's Biggest Winners - Seeking Alpha
April 6, 2021 |  seekingalpha.com
Curaleaf Holdings, Inc. (CURLF) New Branding for Illinois Retail Locations - StreetInsider.com
April 6, 2021 |  streetinsider.com
Cannabis firm Curaleaf opening 10th Illinois retail store - Chicago Business Journal - Chicago Business Journal
April 5, 2021 |  bizjournals.com
This Is Why Curaleaf Is a Great Stock to Buy Right Now - Motley Fool
April 5, 2021 |  fool.com
See More Headlines

MarketRank™

Overall MarketRank™

1.62 out of 5 stars

Medical Sector

376th out of 2,024 stocks

Drug Manufacturers - Specialty & Generic Industry

4th out of 61 stocks

Analyst Opinion: 4.4Community Rank: 3.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$13.84
-0.16 (-1.14 %)
(As of 04/16/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CURLF News and Ratings via Email

Sign-up to receive the latest news and ratings for CURLF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Curaleaf (OTCMKTS:CURLF) Frequently Asked Questions

Is Curaleaf a buy right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Curaleaf in the last year. There are currently 1 sell rating and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Curaleaf stock.
View analyst ratings for Curaleaf or view top-rated stocks.

What stocks does MarketBeat like better than Curaleaf?

Wall Street analysts have given Curaleaf a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Curaleaf wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Curaleaf?

Curaleaf saw a increase in short interest during the month of March. As of March 15th, there was short interest totaling 398,300 shares, an increase of 45.5% from the February 28th total of 273,700 shares. Based on an average daily trading volume, of 3,020,400 shares, the days-to-cover ratio is currently 0.1 days.
View Curaleaf's Short Interest.

How were Curaleaf's earnings last quarter?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) announced its quarterly earnings results on Monday, March, 8th. The company reported ($0.05) EPS for the quarter, missing the Zacks' consensus estimate of ($0.02) by $0.03.
View Curaleaf's earnings history.

How has Curaleaf's stock price been impacted by Coronavirus (COVID-19)?

Curaleaf's stock was trading at $4.42 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CURLF stock has increased by 213.1% and is now trading at $13.84.
View which stocks have been most impacted by COVID-19.

What price target have analysts set for CURLF?

9 Wall Street analysts have issued 1-year price targets for Curaleaf's shares. Their forecasts range from $16.00 to $32.25. On average, they anticipate Curaleaf's share price to reach $22.50 in the next twelve months. This suggests a possible upside of 62.6% from the stock's current price.
View analysts' price targets for Curaleaf or view top-rated stocks among Wall Street analysts.

Who are Curaleaf's key executives?

Curaleaf's management team includes the following people:
  • Mr. Boris Alexis Jordan, Exec. Chairman (Age 55, Pay $750k)
  • Mr. Joseph F. Lusardi, Exec. Vice-Chairman (Age 46, Pay $1.01M)
  • Mr. Neil P. Davidson CPA, COO & Treasurer (Age 49, Pay $538.5k)
  • Mr. Joseph Daniel Bayern, Chief Exec. Officer (Age 58)
  • Mr. Michael J. Carlotti, Chief Financial Officer (Age 50)
  • Mr. Carlos Madrazo, Sr. VP of Investor Relations & Capital Markets
  • Mr. Peter Clateman, Chief Legal Officer (Age 53)
  • Mr. James S. Shorris, Chief Compliance Officer (Age 60)
  • Ms. Tracy Brady, VP of Corp. Communications
  • Mr. Jason White, Chief Marketing Officer (Age 44)

Who are some of Curaleaf's key competitors?

Some companies that are related to Curaleaf include (THCX.V) (THCX), 31444 (GLH), 438280 (ACG), 815446 (HC), Abacus Health Products (ABAHF), Acreage (ACRGF), Althea Group (AGH), Applied Biosciences (APPB), AusCann Group (AC8), Ayr Strategies (AYRSF), Bio-Rad Laboratories (BIO), Blueberries Medical (BBM), Can B (CANB), Cannara Biotech (LOVE) and CannPal Animal Therapeutics (CP1).
View all of CURLF's competitors.

What is Curaleaf's stock symbol?

Curaleaf trades on the OTCMKTS under the ticker symbol "CURLF."

How do I buy shares of Curaleaf?

Shares of CURLF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Curaleaf's stock price today?

One share of CURLF stock can currently be purchased for approximately $13.84.

What is Curaleaf's official website?

The official website for Curaleaf is www.curaleaf.com.

How can I contact Curaleaf?

The company can be reached via phone at 781-451-0150.


This page was last updated on 4/18/2021 by MarketBeat.com Staff

As Featured By:

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.